title: Phase II trial of caracemide (NSC 253272) in advanced unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study.
authors.affiliation: Department of Medicine, University of Illinois, Chicago.
authors.forename: T
authors.initials: T
authors.lastname: Lad
authors.forename: J
authors.initials: J
authors.lastname: Schor
authors.forename: M
authors.initials: M
authors.lastname: Mullane
authors.forename: R
authors.initials: R
authors.lastname: Carroll
authors.forename: D
authors.initials: D
authors.lastname: Chernicoff
authors.forename: R
authors.initials: R
authors.lastname: Blough
authors.forename: L
authors.initials: L
authors.lastname: Weidner
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D000970:Antineoplastic Agents; C044466:caracemide; D006918:Hydroxyurea